Read + Share
Zhou T, Liu J, Xie Y, Yuan S, et al. ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer
stemness by downregulating CXCR4. Gut 2021 Mar 5. pii: gutjnl-2020-321952. doi: 10.1136/gutjnl-2020-321952.
PMID: 33674341
|
 |
|
Zhou T, Liu J, Xie Y, Yuan S, et al. ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer
stemness by downregulating CXCR4. Gut 2021 Mar 5. pii: gutjnl-2020-321952. doi: 10.1136/gutjnl-2020-321952.
PMID: 33674341
|
|
|
|